Your knee cartilage is one of the most remarkable tissues in the body, until it isn't. Unlike skin or bone, articular cartilage has virtually no blood supply, which means it cannot repair itself after injury. For millions of active adults, a cartilage defect spells a future of chronic pain, limited mobility, and the looming threat of early arthritis. But cutting-edge regenerative surgery is rewriting that story, and MACI is leading the way.
What Is MACI, and Why Does It Matter?
MACI stands for Matrix-Induced Autologous Chondrocyte Implantation. It is the third-generation evolution of autologous chondrocyte implantation (ACI), a technique that uses your own living cartilage cells, called chondrocytes, to rebuild damaged tissue inside the knee joint. Unlike earlier approaches that required periosteal patches and suturing, MACI delivers cells on a biodegradable collagen scaffold that is precisely fitted and secured with fibrin glue, making the procedure more reliable, reproducible, and technically refined.
Approved by the FDA in 2016, MACI is currently the only FDA-approved cell-based cartilage repair therapy for the knee in the United States.
The Biology: Why Cartilage Can't Heal on Its Own
Articular cartilage, the smooth, white tissue that cushions the ends of your bones, is avascular and aneural, meaning it has no blood vessels or nerve supply of its own. This is actually why deep cartilage damage is often painless at first, but it is also why the body cannot mount a meaningful healing response. Without blood flow, there are no stem cells or immune cells arriving to rebuild what has been lost.
When left untreated, even focal cartilage defects can progress, eroding the surrounding tissue and ultimately leading to osteoarthritis. This is why early, biologics-based intervention matters.
Step One: Harvesting Your Own Chondrocytes
MACI is a two-stage procedure, and the first stage begins with you.
During a minimally invasive arthroscopic procedure, your surgeon harvests a small cartilage biopsy, typically from a non-weight-bearing region of your knee. The sample is collected from healthy cartilage, ensuring the extracted cells retain the right biological programming.
That tissue is then sent to a certified laboratory, where the chondrocytes are isolated, expanded, and multiplied over a period of 4 to 6 weeks. Remarkably, the cells can also be cryopreserved for up to two years, giving patients flexibility in timing their second procedure.
Step Two: The Biodegradable Scaffold Becomes Living Cartilage
What distinguishes MACI from earlier cartilage repair techniques is its use of a Type I/III collagen membrane as a three-dimensional scaffold. This biocompatible matrix does far more than simply hold the cells in place.
Research published in PubMed has shown that chondrocytes seeded onto the scaffold maintain their spherical shape and continue expressing key markers of healthy, functioning cartilage cells. The scaffold's architecture promotes cell proliferation, stable phenotype expression, and active extracellular matrix production, progressively increasing the mechanical stiffness of the regenerating tissue.
Once the cells are seeded and ready, the implant is trimmed to fit the exact shape of the patient's cartilage defect, like a custom-cut biological patch, and secured with fibrin glue during the second surgical procedure.
What the Research Shows: Hyaline-Like Cartilage, Not Scar Tissue
The goal of MACI is not simply to fill a defect, it is to regenerate hyaline-like cartilage, the gold standard tissue that closely mimics native articular cartilage in both composition and mechanical behavior.
Histological studies have detected early cartilage-like tissue formation as soon as 21 days after implantation, with approximately 75% hyaline-like regeneration observed at 6 months.
Long-term clinical data is equally encouraging. A 15-to-17-year follow-up study confirmed sustained clinical improvement in patients treated with matrix-associated ACI. The landmark SUMMIT trial, a multicenter randomized controlled study, demonstrated that MACI produced statistically superior improvements in knee pain and function compared to microfracture at both 2 and 5 years post-treatment, particularly for defects 3 cm² or larger.
Who Is a Candidate for MACI?
MACI is best suited for patients with:
- Symptomatic focal cartilage defects of the knee
- Defects with minimal subchondral bone involvement
- Active individuals seeking to return to sports or high-demand activities
- Patients who have not responded to conservative management
- Those with patellar instability that has caused cartilage degeneration
Candidates are evaluated with a thorough physical examination and MRI imaging to characterize the size, depth, and location of the defect, as well as the integrity of surrounding structures.
MACI Recovery: A Process Worth the Investment
MACI recovery is a staged, biology-driven process. Most patients follow a structured physical therapy protocol designed to protect the regenerating cartilage while progressively introducing load and movement. General milestones include:
- Weeks 1–6: Protected weight-bearing, range-of-motion exercises
- Months 2–4: Progressive strengthening, low-impact activity
- Months 4–9: Sport-specific rehabilitation and functional training
- Month 12+: Return to full athletic activity for most patients
The cartilage continues to mature and strengthen well beyond the initial months, which is why the long-term outcomes data for MACI is so compelling.
MACI at Boston Joint Preservation
At the practice of Kai Mithoefer, MD, MACI is part of a comprehensive approach to joint preservation that prioritizes keeping your native joint healthy, functional, and pain-free for as long as possible. As an internationally recognized specialist in cartilage restoration, regenerative orthopedics, and sports medicine, with training at Harvard and the Hospital for Special Surgery, Dr. Mithoefer brings world-class expertise to every patient's individualized care plan.
Frequently Asked Questions (FAQ)
Q: What is MACI surgery? MACI (Matrix-Induced Autologous Chondrocyte Implantation) is a two-stage procedure in which a patient's own cartilage cells are harvested, expanded in a laboratory, seeded onto a collagen scaffold, and surgically implanted to repair a cartilage defect in the knee.
Q: How long does MACI surgery take? The second-stage implantation procedure typically takes 1–2 hours and is performed under general or regional anesthesia. The first-stage arthroscopic biopsy is shorter, usually under an hour.
Q: Is MACI better than microfracture? For larger defects (3 cm² or greater), clinical trial data from the SUMMIT study shows that MACI produces significantly better pain and functional outcomes at both 2 and 5 years compared to microfracture. Microfracture generates fibrocartilage, while MACI generates hyaline-like cartilage, which is biomechanically superior.
Q: How long does MACI recovery take? Full return to athletic activity generally takes 12 months or more. However, most patients are walking and beginning rehabilitation within the first few weeks. The cartilage continues to mature for up to 2 years after implantation.
Q: Is MACI covered by insurance? MACI is FDA-approved and is covered by many major insurance plans for appropriate indications. Coverage depends on your specific insurer and plan. Our office team can assist with insurance verification and prior authorization.
Q: Can MACI be used for the shoulder or other joints? Currently, MACI is FDA-approved specifically for cartilage repair in the knee. Research into its application in other joints is ongoing.
Q: How do I know if I am a candidate for MACI? A consultation with Dr. Mithoefer, including a physical exam and MRI evaluation, will determine whether you have a focal cartilage defect appropriate for MACI. Ideal candidates are active individuals with symptomatic defects who have not found relief through conservative measures.
Q: What makes MACI different from a cartilage transplant (OATS)? MACI uses your own cells grown on a scaffold to fill defects of virtually any shape, while OATS (Osteochondral Autograft Transfer System) involves transplanting plugs of cartilage and bone from one part of the knee to another. MACI is generally preferred for larger or irregularly shaped defects.
Reference Links:
- Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation - PubMed
- Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment - PubMed
- Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial - PubMed
- Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study - PubMed
- Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients - PubMed Central
- Matrix-Associated Autologous Chondrocyte Implantation: A Clinical Follow-Up at 15 Years - PubMed Central
New and Emerging Techniques in Cartilage Repair: MACI - PubMed Central - Is implantation of autologous chondrocytes superior to microfracture for articular-cartilage defects of the knee? A systematic review of 5-year follow-up data - PubMed
AUTHOR: Kai Mithoefer, MD – Orthopedic Surgeon & Sports Medicine Specialist
Kai Mithoefer, MD is a board-certified orthopedic surgeon with dual certification in orthopedic surgery and orthopedic sports medicine. He is an internationally recognized specialist in sports medicine, joint preservation, and regenerative orthopedics with more than 15 years of clinical experience. Dr. Mithoefer is dedicated to helping athletes and active individuals return safely and efficiently to sports and work through advanced, patient-centered musculoskeletal care.
Credentials & Training
After completing medical school in Germany, Dr. Mithoefer trained in the Harvard Orthopedic Residency Program. He went on to complete a fellowship in Orthopedic Trauma at Harvard, followed by the prestigious Sports Medicine and Shoulder Surgery fellowship at the Hospital for Special Surgery in New York.
Dr. Mithoefer has been recognized as a Top Doctor by Castle Connolly and Boston Magazine every year since 2019 and continues this distinction through 2026. He has published more than 100 scientific articles and book chapters and is a frequent invited speaker at national and international orthopedic conferences.
Clinical Expertise
Dr. Mithoefer specializes in minimally invasive surgical techniques, joint preservation strategies, and regenerative orthopedic treatments designed to accelerate recovery and restore function. His expertise includes state-of-the-art biologic therapies and comprehensive musculoskeletal care tailored to each patient’s specific needs. Drawing from his own experience as a competitive and recreational athlete, he understands the demands of sports participation and prioritizes safe, efficient return to activity.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Kai Mithoefer or another qualified orthopedic specialist.
